Actelion (Actelion) Cash Flow for Lease Financing : $0 Mil (TTM As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Cash Flow for Lease Financing?

Actelion's Cash Flow for Lease Financing for the three months ended in Mar. 2017 was $0 Mil. Actelion's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2017 was $0 Mil.

Compared with last quarter ($0 Mil in Dec. 2016 ), Actelion's Cash Flow for Lease Financing remained the same in Mar. 2017 ($0 Mil).

Actelion Cash Flow for Lease Financing Historical Data

The historical data trend for Actelion's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Cash Flow for Lease Financing Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-	-	-	-	-

Actelion Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Actelion Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Actelion's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017